BACKGROUND AND OBJECTIVES: Despite high mortality and low levels of physical activity (PA) among patients starting dialysis, the link between low PA and mortality has not been carefully evaluated. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The Comprehensive Dialysis Study was a prospective cohort study that enrolled patients who started dialysis between June 2005 and June 2007 in a random sample of dialysis facilities in the United States. The Human Activity Profile (HAP) was administered to estimate PA among 1554 ambulatory enrolled patients in the Comprehensive Dialysis Study. Patients were followed until death or September 30, 2009, and the major outcome was all-cause mortality. RESULTS: The average age was 59.8 (14.2) years; 55% of participants were male, 28% were black, and 56% had diabetes mellitus. The majority (57.3%) had low fitness estimated from the HAP score. The median follow-up was 2.6 (interquartile range, 2.2-3.1) years. The association between PA and mortality was linear across the range of scores (1-94). After multivariable adjustment, lower adjusted activity score on the HAP was associated with higher mortality (hazard ratio, 1.30; 95% confidence interval, 1.23-1.39 per 10 points). Patients in the lowest level of fitness experienced a 3.5-fold (95% confidence interval, 2.54-4.89) increase in risk of death compared with those with average or above fitness. CONCLUSIONS: Low levels of PA are strongly associated with mortality among patients new to dialysis. Interventions aimed to preserve or enhance PA should be prospectively tested.
BACKGROUND AND OBJECTIVES: Despite high mortality and low levels of physical activity (PA) among patients starting dialysis, the link between low PA and mortality has not been carefully evaluated. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The Comprehensive Dialysis Study was a prospective cohort study that enrolled patients who started dialysis between June 2005 and June 2007 in a random sample of dialysis facilities in the United States. The Human Activity Profile (HAP) was administered to estimate PA among 1554 ambulatory enrolled patients in the Comprehensive Dialysis Study. Patients were followed until death or September 30, 2009, and the major outcome was all-cause mortality. RESULTS: The average age was 59.8 (14.2) years; 55% of participants were male, 28% were black, and 56% had diabetes mellitus. The majority (57.3%) had low fitness estimated from the HAP score. The median follow-up was 2.6 (interquartile range, 2.2-3.1) years. The association between PA and mortality was linear across the range of scores (1-94). After multivariable adjustment, lower adjusted activity score on the HAP was associated with higher mortality (hazard ratio, 1.30; 95% confidence interval, 1.23-1.39 per 10 points). Patients in the lowest level of fitness experienced a 3.5-fold (95% confidence interval, 2.54-4.89) increase in risk of death compared with those with average or above fitness. CONCLUSIONS: Low levels of PA are strongly associated with mortality among patients new to dialysis. Interventions aimed to preserve or enhance PA should be prospectively tested.
Authors: Kirsten L Johansen; Glenn M Chertow; Nancy G Kutner; Lorien S Dalrymple; Barbara A Grimes; George A Kaysen Journal: Kidney Int Date: 2010-09-01 Impact factor: 10.612
Authors: K L Johansen; G M Chertow; A V Ng; K Mulligan; S Carey; P Y Schoenfeld; J A Kent-Braun Journal: Kidney Int Date: 2000-06 Impact factor: 10.612
Authors: Kamyar Kalantar-Zadeh; Kevin C Abbott; Abdulla K Salahudeen; Ryan D Kilpatrick; Tamara B Horwich Journal: Am J Clin Nutr Date: 2005-03 Impact factor: 7.045
Authors: Dinanda J de Jager; Diana C Grootendorst; Kitty J Jager; Paul C van Dijk; Lonneke M J Tomas; David Ansell; Frederic Collart; Patrik Finne; James G Heaf; Johan De Meester; Jack F M Wetzels; Frits R Rosendaal; Friedo W Dekker Journal: JAMA Date: 2009-10-28 Impact factor: 56.272
Authors: Nancy G Kutner; Kirsten L Johansen; George A Kaysen; Sarah Pederson; Shu-Cheng Chen; Lawrence Y Agodoa; Paul W Eggers; Glenn M Chertow Journal: Clin J Am Soc Nephrol Date: 2009-03-04 Impact factor: 8.237
Authors: Dorien M Zelle; Gerald Klaassen; Edwin van Adrichem; Stephan J L Bakker; Eva Corpeleijn; Gerjan Navis Journal: Nat Rev Nephrol Date: 2017-01-31 Impact factor: 28.314
Authors: Antonio Alberto Lopes; Brett Lantz; Hal Morgenstern; Mia Wang; Brian A Bieber; Brenda W Gillespie; Yun Li; Patricia Painter; Stefan H Jacobson; Hugh C Rayner; Donna L Mapes; Raymond C Vanholder; Takeshi Hasegawa; Bruce M Robinson; Ronald L Pisoni Journal: Clin J Am Soc Nephrol Date: 2014-10-02 Impact factor: 8.237
Authors: Gabriela Cobo; Paloma Gallar; Thiane Gama-Axelsson; Cristina Di Gioia; Abdul Rashid Qureshi; Rosa Camacho; Ana Vigil; Olof Heimbürger; Olimpia Ortega; Isabel Rodriguez; Juan Carlos Herrero; Peter Bárány; Bengt Lindholm; Peter Stenvinkel; Juan Jesús Carrero Journal: J Nephrol Date: 2014-12-12 Impact factor: 3.902
Authors: John C Sieverdes; Phyllis A Raynor; Tracy Armstrong; Carolyn H Jenkins; Luke R Sox; Frank A Treiber Journal: Prog Transplant Date: 2015-03 Impact factor: 1.187